Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Prescient Therapeutics, Ltd.
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Columbia University
City of Hope Medical Center
University College, London
4SC AG
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
University of Nebraska
Genmab
OncoSec Medical Incorporated
Genmab
Thomas Jefferson University
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
European Organisation for Research and Treatment of Cancer - EORTC
Rochester General Hospital
Fred Hutchinson Cancer Center
miRagen Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Neumedicines Inc.
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Stanford University
Mayo Clinic
Angimmune LLC
Angimmune LLC
Thomas Jefferson University